DemocratBill · H.R. 9635· House(119-HR-9635)

Getting Innovations to Patients During Shutdowns Act

Rep. Mullin
Age: 56 years
California
Introduced
7/9/2026
Last activity
7/9/2026 — Referred to the House Committee on Energy and Commerce.
Sponsored by
Kevin Mullin
Cosponsors
None
Health
  1. Introduced
  2. In Committee

What this bill would do

This bill is called the Getting Innovations to Patients During Shutdowns Act. It changes the Federal Food, Drug, and Cosmetic Act to deal with government shutdowns. Specifically, it creates special rules for human drug and medical device submissions when there is a lapse in appropriations. During a funding lapse, the Secretary may accept certain drug and device applications even if the required fees have not been paid yet. The bill extends the deadline for paying these fees until 7 days after the shutdown ends. However, if the fees are not paid by that new deadline, the application will be considered incomplete and will not be approved.

Yes· 3 of 11

  • Does this make health care easier to get in general?+3

    Ensures the FDA can continue processing human drug and medical device submissions during funding lapses, helping innovations reach patients faster.

  • Would people over 65 be better off under this?+2

    Seniors heavily rely on new drugs and medical devices, making uninterrupted FDA reviews advantageous.

  • Would business owners be better off under this?+2

    Helps medical product developers avoid costly delays during government shutdowns.

The opposite

No question was scored the opposite.